In his inaugural address, President Daniel Coit Gilman, the University’s first president, made a statement on what he expects ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

The Johns Hopkins Occupational Health team has launched a major upgrade to Cority, the software used to store and manage the ...

Engineer Denis Wirtz and colleagues are using artificial intelligence and multiscale imaging to reveal how tumors grow, ...